Hunan Warrant Pharmaceutical Co.,Ltd (SHA:688799)
44.73
+1.16 (2.66%)
At close: Mar 10, 2026
SHA:688799 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 5,874 | 6,264 | 3,928 | 4,591 | 2,986 | 3,862 | Upgrade
|
| Market Cap Growth | 51.52% | 59.46% | -14.43% | 53.75% | -22.69% | - | Upgrade
|
| Enterprise Value | 5,930 | 6,320 | 3,696 | 4,184 | 2,376 | 3,094 | Upgrade
|
| Last Close Price | 44.73 | 47.70 | 29.57 | 33.83 | 21.51 | 27.21 | Upgrade
|
| PE Ratio | 24.31 | 25.94 | 23.91 | 21.72 | 16.33 | 24.02 | Upgrade
|
| PS Ratio | 3.88 | 4.13 | 2.78 | 3.20 | 2.31 | 3.37 | Upgrade
|
| PB Ratio | 2.95 | 3.14 | 2.15 | 2.60 | 1.80 | 2.61 | Upgrade
|
| P/TBV Ratio | 3.22 | 3.43 | 2.48 | 2.84 | 2.01 | 2.72 | Upgrade
|
| P/FCF Ratio | - | - | - | 42.24 | 125.46 | 170.68 | Upgrade
|
| P/OCF Ratio | - | - | 27.62 | 21.41 | 19.18 | 33.66 | Upgrade
|
| EV/Sales Ratio | 3.91 | 4.17 | 2.62 | 2.92 | 1.84 | 2.70 | Upgrade
|
| EV/EBITDA Ratio | 18.88 | 20.13 | 17.77 | 15.85 | 11.01 | 16.27 | Upgrade
|
| EV/EBIT Ratio | 24.19 | 25.78 | 26.57 | 20.62 | 14.23 | 19.85 | Upgrade
|
| EV/FCF Ratio | - | - | - | 38.50 | 99.86 | 136.75 | Upgrade
|
| Debt / Equity Ratio | 0.18 | 0.18 | 0.07 | 0.01 | - | - | Upgrade
|
| Debt / EBITDA Ratio | 1.12 | 1.12 | 0.57 | 0.06 | - | - | Upgrade
|
| Debt / FCF Ratio | - | - | - | 0.16 | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.03 | 0.03 | -0.30 | -0.41 | -0.42 | -0.51 | Upgrade
|
| Net Debt / EBITDA Ratio | 0.18 | 0.18 | -2.59 | -2.75 | -3.23 | -3.96 | Upgrade
|
| Net Debt / FCF Ratio | - | - | 5.89 | -6.69 | -29.33 | -33.30 | Upgrade
|
| Asset Turnover | - | - | 0.61 | 0.69 | 0.68 | 0.84 | Upgrade
|
| Inventory Turnover | - | - | 1.41 | 1.46 | 1.32 | 1.31 | Upgrade
|
| Quick Ratio | - | - | 2.15 | 2.77 | 2.99 | 3.41 | Upgrade
|
| Current Ratio | - | - | 3.42 | 4.01 | 4.23 | 4.65 | Upgrade
|
| Return on Equity (ROE) | 12.66% | 12.66% | 7.73% | 11.27% | 11.05% | 15.01% | Upgrade
|
| Return on Assets (ROA) | - | - | 3.75% | 6.06% | 5.48% | 7.17% | Upgrade
|
| Return on Invested Capital (ROIC) | 11.77% | 14.47% | 10.28% | 16.89% | 17.61% | 21.25% | Upgrade
|
| Return on Capital Employed (ROCE) | - | - | 6.80% | 11.00% | 9.70% | 10.10% | Upgrade
|
| Earnings Yield | 4.11% | 3.85% | 4.18% | 4.60% | 6.12% | 4.16% | Upgrade
|
| FCF Yield | - | - | -2.33% | 2.37% | 0.80% | 0.59% | Upgrade
|
| Dividend Yield | 0.98% | - | 1.45% | 1.90% | 2.99% | 1.84% | Upgrade
|
| Payout Ratio | - | - | 52.55% | 39.96% | 35.92% | - | Upgrade
|
| Buyback Yield / Dilution | 0.17% | 0.17% | 0.03% | -0.19% | -17.21% | -13.60% | Upgrade
|
| Total Shareholder Return | 1.14% | 0.17% | 1.48% | 1.71% | -14.22% | -11.77% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.